InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,319.31
(
2.30%
)
US TECH 100
18,004.00
(
3.53%
)
Dow Jones
39,446.49
(
1.76%
)
Brent Oil
79.01
(
0.34%
)
Bitcoin
61,415.81
(
-0.52%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Lewis R Goudy

Send PM Follow Ignore
Followers 4
Posts 624
Boards Moderated 0
Alias Born 10/10/2006

Lewis R Goudy

Re: None

Tuesday, 10/24/2006 3:12:20 PM

Tuesday, October 24, 2006 3:12:20 PM

Post# of 19309
Cambrex Selling 2 Businesses for $460M

EAST RUTHERFORD, N.J. (AP) - Life sciences company Cambrex Corp. on Tuesday said it has agreed to sell two of its businesses to Switzerland's Lonza Group AG for $460 million following a review of its operations.

Cambrex said it is selling its bioproducts and biopharma businesses, which accounted for 42 percent of revenue in 2005, to focus on its human health operations.

The bioproducts business makes and sells research, therapeutic and analytical testing products that are based on cell biology and used in drug discovery and biotherapeutic manufacturing. The biopharma business handles contract biopharmaceutical manufacturing and process development...

http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=AP&Date=20061024&ID=61296...
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up